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Comparison among three polymerase chain reaction assays on detection 
of DNA from Leishmania in biological samples from patients with 
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ABSTRACT
Introduction: The study analyzed positivity of polymerase chain reaction 
(PCR) on detection of DNA from Leishmania in patients’ samples. Methods: 
Extracted DNA was submitted to L150/L152, 13Y/13Z, and seminested 
PCR (snPCR). Results: Results were evidenced by bands of approximately 
120, 720, and 670 bp for L150/L152, 13Y/13Z, and snPCR, respectively. 
L150/L152, 13Y/13Z, and snPCR positivity indexes were 76.9, 56.4, and 
69.2 (p>0.05), respectively, for suspected and 93.7, 68.7, and 84.4 (p<0.05), 
respectively, for confirmed. Conclusions: Preliminary results showed that 
these assays, mainly L150/L152 and snPCR, can detect Leishmania DNA 
and carry potential on laboratory diagnosis of leishmaniasis.
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RESUMO
Introdução: Analisou-se a positividade da reação em cadeia da polimerase 
(PCR) na detecção de DNA de Leishmania em pacientes. Métodos: DNA 
extraído foi submetido a L150/L152, 13Y/13Z e PCR seminested (snPCR). 
Resultados: Resultados foram evidenciados por bandas de aproximadamente 
120; 720 e 670pb para L150/L152, 13Y/13Z e snPCR, respectivamente. 
Positividades para L150/L152, 13Y/13Z e snPCR foram 76,9; 56,4 e 69,2 
(p > 0,05), para suspeitos; e 93,7; 68,7 e 84,4 (p < 0,05) para confirmados, 
respectivamente. Conclusões: Resultados preliminares mostraram que os 
ensaios, principalmente L150/L152 e snPCR, podem detectar DNA de 
Leishmania e têm potencial para diagnóstico laboratorial das leishmanioses.
Palavras-chaves:  Leishmania. PCR. Diagnóstico.
Leishmaniases are caused by an intracellular protozoan of the 
genus Leishmania, whose promastigote forms can be transmitted to 
humans by the bite of Lutzomyia female insect, also known as sandfly1.
Leishmania infection occurs in most Brazilian states, and some 
authors believe that its dispersal is associated to anthroponotic action. 
The traditional clinical manifestations for American cutaneous 
leishmaniasis (ACL) are single or multiple cutaneous lesions, but 
there are asymptomatic cases as well1.
The laboratory techniques of diagnosis involve methods of 
detection of the parasite, such as direct search, isolation in culture, animal 
inoculation, and histopathology. However, these methods present 
hurdles related to sensitivity1. On the other hand, immunodiagnostic 
techniques, such as the Montenegro skin test (MST), can increase 
the speed of the diagnosis, but they are unable to distinguish among 
active, inactive, or past infection2. Historically, a positive MST is 
an indicator of previous contact with the parasite through natural 
inoculation. MST is the most widely used complementary test 
for the presumptive diagnosis of Leishmania infection. Positivity 
indexes of 84% and 100% have been estimated in cutaneous and 
mucocutaneous forms, respectively. Moreover, MST is negative 
in cutaneous diffuse form and in immunocompromised patients2.
In this context, the use of PCR-based techniques has been 
shown as a new option of diagnosis, mainly due to their speed and 
high sensitivity1, 3. Moreover, these techniques have been developed 
to amplify mini-exon genes4, DNA coding regions for subunits of 
the ribosomal RNA5, and kinetoplast DNA-kDNA6 besides other 
sequences of nuclear DNA7 in clinical samples for the diagnosis 
of leishmaniasis. However, a major concern in the development 
and implementation of PCR for Leishmania diagnosis is the lack of 
standardization; many reports have been published, but very few 
studies have compared the different protocols5.
One of the main targets of these protocols is the kDNA that 
contains minicircles, which usually have the size of 1kb and occur 
up to 10,000 copies per parasite8. The minicircle kDNA has a 
denominated region conserved, with approximately 100–150 bp, 
and a variable one, with approximately 700-1,000bp. Both regions 
are targets for primers designed to the PCR8, 9.
In this work, primers directed to the conserved region — L150/
L1529 — and to the variable region — 13Y/13Z8 — were used in the 
PCR. In seminested PCR (snPCR), primers LINR4/LIN17/LIN19 
were used to target the variable region, although their alignment 
was with the conserved region6. The positivity of those methods 
was assessed based on the analysis of the materials obtained from 
patients suspected for ACL.
For this purpose, DNA was obtained from 39 samples (biopsies 
and imprints on slides) of patients with suggestive lesions for ACL. 
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TABLE 1 - Indices of positivity obtained for the PCR-based techniques applied 
on biological samples from ACL suspected and confirmed patients.
                                                         Positivity index PCR (%)*
 ACL suspected (n=39) PAR and/or MST+ (n=32)
PCR technique n % n %
13Y/13Z 22 56.4a 22 68.7a
L150/L152 30 76.9a 30 93.7b
snPCR 27 69.2a 27 84.4a, b
PCR: polymerase chain reaction, snPCR: seminested PCR, ACL: American 
cutaneous leishmaniasis, PAR: parasitological, MST+: Montenegro skin test, 
*Chi-square test (significant at p<0.05); a, b: equal letters mean positivity indexes 
that are statistically similar.
The patients were from the regions of Southern, Southwestern 
(SSMG), and Rio Doce Valley (RDV), State of Minas Gerais. Among 
those patients, 32 (82%) out of 39 were confirmed positive for ACL 
by parasitological diagnosis and/or MST. Parasitological diagnosis 
was done under microscopic analysis of imprints obtained from 
outer edges of the lesions.
All procedures involving human samples were approved under 
register number 141/2006 by the Ethics on Human Research 
Committee from Universidade Federal de Alfenas.
DNA extraction was carried out using proteinase K digestion of 
skin biopsies from lesions9. In this methodology, DNA extraction 
from samples was performed with 100µL buffer solution (10 mmol/L 
Tris-HCl and 1 mmol/L ethylenediaminetetraacetic acid, pH 8.0) 
and 100µg/mL proteinase K (final concentration), incubated at 56ºC 
for 3h, and homogenized from time to time. Digestion was stopped by 
proteinase K inactivation, by boiling it for 15 min. The samples were 
centrifuged, and the supernatant was used as the Leishmania template 
DNA source for the PCR reaction. For slides, the methodology 
used was extraction based on heating10. In this methodology, an 
area covering two imprints, previously analyzed on microscope, 
was scraped from each slide with a toothpick, resuspended in 20µL 
of double-distilled water, and transferred to 0.5mL microtubes. The 
samples were heated at 70ºC for 10 min and, then, centrifuged at 
12,000 g for 5 min at room temperature; after which, the supernatant 
was used as a DNA template.
DNA obtained from the digestion of biopsies as well as the 
imprints was submitted to the following three PCR techniques. 
Amplification was carried out in a Perkin-Elmer GeneAmp® PCR 
System 9,700 thermocycler under different conditions for L150/
L1529, 13Y/13Z8, and snPCR6.
For each reaction, a negative control tube containing no template 
DNA was included. The positive control was also performed 
consisting of 10 pg of DNA extracted from axenic cultures of 
Leishmania (Viannia) braziliensis MHOM/BR/1975/M2903 and 
Leishmania (Leishmania) amazonensis MHOM/BR/1972/M2269. 
Amplified products were analyzed in a 1.5% agarose gel, which was 
stained with ethidium bromide and under 3 V/cm.
Comparative analysis among the positivity indexes obtained by 
the three PCR techniques was carried out using the Chi-square test, 
with the level of significance set at p<0.05. The analysis was carried 
out using the Epi Info™ 6.04d (CDC) software9.
Results were evidenced by a band of approximately 120, 720, and 
670 bp for L150/L152, 13Y/13Z, and snPCR, respectively (Figure 1). 
The positivity indexes obtained by the three techniques can be seen on 
Table 1. For ACL suspected cases, a larger percentage of positive results 
was detected in the L150/L152 PCR (76.9%) in relation to others 
assays, although without significant difference (p>0.05), which was 
probably due the small number of cases. However, for confirmed cases, 
in parasitological tests and/or MST, these results were significantly 
different (p<0.05).
The performance of L150/L152 in the present work confirmed 
the results obtained from previous studies9. However, it was noted that 
the snPCR technique has the possibility of detecting and amplifying 
larger sizes of DNA fragments with similar positivity obtained 
by L150/L152. Larger DNA targets present lower efficiency of 
amplification11; however, the opposite was observed in the positivity 
index of snPCR from ACL suspected and confirmed patients.
It was proposed that snPCR test is very sensitive on detection of 
Leishmania, partly because there can be about 10,000 minicircles per 
kinetoplast and because its sequences are known for most Leishmania 
species3. Results obtained by Nested PCR using other targets as 
ITS-1 showed a lower positivity when compared with snPCR using 
the kDNA5.
Trypanosoma cruzi  DNA was tested by L150/L152, 13Y/13Z, 
and snPCR to verify possible cross-reaction, but specific fragments were 
not observed (data not shown). In addition, results of PCR obtained for 
Leishmania using 13Y/13Z primers8 as well as snPCR3, 6 did not show 
cross-reactivity with other trypanosomatids. Cross-reaction and low 
specificity for L150/L15212 were observed. Furthermore, to minimize 
risks of contamination, improvements were done in snPCR in relation 
to the conventional Nested technique13.
Moreover, it was proposed that the control of leishmaniasis in 
areas of endemicity requires a thorough knowledge of Leishmania 
ecology and epidemiology and a sensible method for the detection 
of the parasite, which can be capable of processing a large number 
of samples synchronously6. In this context, results obtained in three 
PCR assays show that these techniques can be useful for this purpose. 
Additionally, these methodologies have been shown capable of 
detecting kDNA from Leishmania in imprints on slides, where the 
shortage of material is not a limiting factor10.
In conclusion, the preliminary results showed that three PCR 
assays, mainly L150/L152 and snPCR, can detect Leishmania 
DNA, including those in biological samples from ACL patients, and 
FIGURE 1 - Representative 1.5% agarose gel showing amplification products of 120 
(lanes 2-6, conserved region with L150/L152 primers), approximately 720 (lanes 7-11, 
variable region with 13Y/13Z primers), and approximately 670 (lanes 12-16, variable 
region with PCR Seminested) bp from kDNA minicircles of Leishmania in promastigote 
cultures and skin biopsies from american cutaneous leishmaniasis patients. 
Lane 1: Molecular size marker of 100 bp ladder; Lanes 2, 7, and 12: DNA from 
Leishmania (Viannia) braziliensis MHOM/BR/1975/M2903; Lanes 3, 8, and 13: 
DNA from Leishmania (Leishmania) amazonensis MHOM/BR/1972/M2269; Lane 
4-5, 9-10, and 14-15: DNA of skin biopsy samples from ACL patients;  Lanes 6, 
11, and 16: negative controls.
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